Performance of Contactless Respiratory Rate Monitoring by Albus HomeTM, an Automated System for Nocturnal Monitoring at Home: A Validation Study
Journal article
Do W. et al, (2022), Sensors, 22, 7142 - 7142
Performance of cough monitoring by Albus Home™, a contactless and automated system for nocturnal respiratory monitoring at home
Journal article
Do W. et al, (2022), ERJ Open Research, 00265 - 2022
Early Th2 inflammation in the upper respiratory mucosa as a predictor of severe COVID-19 and modulation by early treatment with inhaled corticosteroids: a mechanistic analysis
Journal article
Baker JR. et al, (2022), The Lancet Respiratory Medicine, 10, 545 - 556
Discordant diagnostic criteria for pneumonia in COPD trials: a review
Journal article
Wise RA. et al, (2021), European Respiratory Review, 30, 210124 - 210124
Dampening of the respiratory cytokine storm is promoted by inhaled budesonide in patients with early COVID-19
Preprint
Baker JR. et al, (2021)
A new piece in the puzzle: the eosinophil and the development of COPD
Journal article
Petousi N. et al, (2021), European Respiratory Journal, 58, 2101105 - 2101105
Renaming COPD exacerbations: the UK respiratory nursing perspective.
Journal article
Mwasuku C. et al, (2021), BMC pulmonary medicine, 21
Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
Journal article
Yu L-M. et al, (2021), The Lancet, 398, 843 - 855
Predicting treatment outcomes following an exacerbation of airways disease
Journal article
Halner A. et al, (2021), PLOS ONE, 16, e0254425 - e0254425
Inhaled budesonide for COVID-19 in people at higher risk of adverse outcomes in the community: interim analyses from the PRINCIPLE trial
Journal article
Yu L-M. et al, (2021)
Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial
Journal article
Ramakrishnan S. et al, (2021), The Lancet Respiratory Medicine
30-day readmission after an acute exacerbation of chronic obstructive pulmonary disease is associated with cardiovascular comorbidity
Journal article
Alpaydin AO. et al, (2021), Turkish Thoracic Journal, 22, 369 - 375
Finding the true prevalence of obstructive lung disease: two steps forward and one step back
Journal article
Russell REK. and Wang K., (2020), European Respiratory Journal, 55, 2001514 - 2001514
The Use of Benralizumab in the Treatment of Near-Fatal Asthma: A New Approach
Journal article
Ramakrishnan S. et al, (2020), American Journal of Respiratory and Critical Care Medicine, 201, 1441 - 1443
Chronic obstructive pulmonary disease: management of chronic disease
Journal article
Ramakrishnan S. et al, (2020), Medicine, 48, 333 - 336
Evaluating the sensitivity and specificity of NEATstik technology compared to an activity-based immunoassay in sputum samples from participants with COPD
Journal article
Thulborn SJ. et al, (2020), European Respiratory Journal, 55, 1902412 - 1902412
Covid-19 and COPD: A Personal Reflection
Journal article
Russell R., (2020), International Journal of Chronic Obstructive Pulmonary Disease, Volume 15, 883 - 884
Exacerbations of chronic obstructive pulmonary disease: time to rename.
Journal article
Bafadhel M. et al, (2020), The Lancet. Respiratory medicine, 8, 133 - 135
“Breathing New Life Into Chronic Obstructive Pulmonary Disease (COPD)” – Results From An Online Survey Of UK Patients
Journal article
Titmarsh S. et al, (2019), International Journal of Chronic Obstructive Pulmonary Disease, Volume 14, 2799 - 2807
In the race at last: post-hoc analysis of GALATHEA and TERRANOVA.
Journal article
Ramakrishnan S. and Russell R., (2019), The Lancet. Respiratory medicine